Involuntarytransformation.blogspot.com

Innov Clin Neurosci. 2015;12(5–6 Suppl B):3–19 Click here to access the e-Edition, a digital replica of the printed version. CNS Drug Compounds/Therapies/Devices Long-acting injectable antipsychotics (LAIs) in outpatient treatment of DMS-IV-R schizophrenia...

Last October, Virology Blog posted David Tuller’s 14,000-word investigation of the many flaws of the PACE trial (link to article), which had reported that cognitive behavior therapy and graded exercise therapy could lead to “improvement” and “recovery...

This is post #120 on the site, about several biased, anti-supplement articles Dr. David Seres has written, published on the CNN website. The following information will debunk Dr. Seres’ claims and provide more accurate perspective and balance on his...

Study Citations: Shrestha N, Kukkonen-Harjula KT, Verbeek JH, Ijaz S, Hermans V, Bhaumik S. Workplace interventions for reducing sitting at work. Cochrane Database of Systematic Reviews. 2016; 3: CD010912. Angadi SS, Weltman A, Watson-Winfield D, Weltman...

Quote Lanicemine (AZD6765) is an NMDA antagonist developed by AstraZeneca,[1] which is being studied for the treatment of major depression. It was originally developed as a neuroprotective agent, but was redeveloped as an antidepressant following the...